ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Epigenetic silencing of tumor-related genes via promoter hypermethylation is a key mechanism in cancer development.
• The ATP-binding cassette sub-family B member 4 (ABCB4) gene was investigated as a potential epigenetically silenced target.

Purpose of the Study:

• To investigate the epigenetic regulation and potential tumor-suppressive role of ABCB4 in various human cancers.
• To determine the frequency of ABCB4 promoter hypermethylation and its correlation with gene expression in cancer cell lines and primary tumors.

Main Methods:

• Methylation and gene expression analysis were performed on 26 human cancer cell lines (lung, breast, skin, liver, head and neck) and primary cancer tissues.
• Cancer cells were treated with demethylating agents (5-aza-2'-deoxycytidine and zebularine) to assess ABCB4 re-expression.
• Functional studies involved overexpressing ABCB4 in lung cancer cells to evaluate its effect on proliferation and colony formation.

Main Results:

• ABCB4 promoter hypermethylation was identified in 62% of cancer cell lines and in primary lung (39%) and head and neck (20%) cancers.
• Significant hypermethylation of ABCB4 was observed in breast tumor tissues compared to normal samples (41% vs 0%).
• ABCB4 expression was absent in 37% of primary lung cancers; demethylating agents restored ABCB4 expression, and its overexpression suppressed lung cancer cell proliferation.

Conclusions:

• ABCB4 is frequently epigenetically silenced in diverse human cancers.
• ABCB4 exhibits tumor-suppressive functions, particularly in lung cancer, making it a potential therapeutic target.